The Cutting Edge of Medical Technology Content, Community & Collaboration
NIH "Stimulus" SBIR Letters of Intent: Due 3 August for "Biomedical Research, Development, and Growth to Spur the Acceleration of New Technologies"
Colleagues,
Just a reminder for U.S. members of "MedTech-IQ" ... This Funding Opportunity Announcement (FOA), supported by funds provided to the NIH under the American Recovery & Reinvestment Act of 2009 ("Stimulus", “Recovery Act” or “ARRA”), is soliciting grant applications to address the funding gap between promising research and development (R&D) and transitioning to the market -- often called the “Valley of Death -- by contributing to the critical funding needed by applicants to pursue the next appropriate milestone(s) toward ultimate commercialization; i.e., to carry out later stage research activities necessary to that end. This program aims to accelerate the transition of research innovations and technologies toward the development of products or services that will improve human health, help advance the mission of NIH and its Institutes and Centers (ICs), and create significant value and economic stimulus.
... NIH intends to commit at least $35 million in response to this FOA ... The requested budget is limited to $1 million total costs per year for a maximum of three years ... A U.S.-owned, for-profit enterprise/commercial organization doing a majority of its business in the United States may apply for funding.
The Biomedical Research, Development, and Growth to Spur the Acceleration of New Technologies (BRDG-SPAN) pilot program encourages projects representing, for example, the following:
* a novel, “first in class” therapy;
* a material improvement over existing technologies;
* a potential substantial reduction in cost over existing technologies/products;
* U.S. alternative to foreign suppliers;
* a product for unmet, under-addressed medical needs (e.g., technologies to produce solid medication dosage forms for children, and therapeutic devices appropriate for children in terms of size and functionality)
* a significant and demonstrable potential U.S. and/or global markets;
Read on at: http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-09-008.html
ENJOY!
CC
Just a reminder for U.S. members of "MedTech-IQ" ... This Funding Opportunity Announcement (FOA), supported by funds provided to the NIH under the American Recovery & Reinvestment Act of 2009 ("Stimulus", “Recovery Act” or “ARRA”), is soliciting grant applications to address the funding gap between promising research and development (R&D) and transitioning to the market -- often called the “Valley of Death -- by contributing to the critical funding needed by applicants to pursue the next appropriate milestone(s) toward ultimate commercialization; i.e., to carry out later stage research activities necessary to that end. This program aims to accelerate the transition of research innovations and technologies toward the development of products or services that will improve human health, help advance the mission of NIH and its Institutes and Centers (ICs), and create significant value and economic stimulus.
... NIH intends to commit at least $35 million in response to this FOA ... The requested budget is limited to $1 million total costs per year for a maximum of three years ... A U.S.-owned, for-profit enterprise/commercial organization doing a majority of its business in the United States may apply for funding.
The Biomedical Research, Development, and Growth to Spur the Acceleration of New Technologies (BRDG-SPAN) pilot program encourages projects representing, for example, the following:
* a novel, “first in class” therapy;
* a material improvement over existing technologies;
* a potential substantial reduction in cost over existing technologies/products;
* U.S. alternative to foreign suppliers;
* a product for unmet, under-addressed medical needs (e.g., technologies to produce solid medication dosage forms for children, and therapeutic devices appropriate for children in terms of size and functionality)
* a significant and demonstrable potential U.S. and/or global markets;
Read on at: http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-09-008.html
ENJOY!
CC
Views: 0
MedTechIQ VideoLibrary
Upcoming Events
© 2024 Created by CC-Conrad Clyburn-MedForeSight.
Powered by
